Making Tumor Treatment Less ComplicatedMaking Tumor Treatment Less Complicated

Roche and GE Healthcare are releasing, the Navify Tumor Board, a solution that allows healthcare professionals to have complete patient diagnostic information in one location.

Omar Ford

June 3, 2019

1 Min Read
Making Tumor Treatment Less Complicated
Pixabay

Roche and GE Healthcare are releasing the first product from their oncology collaboration.

The duo’s product, the Navify Tumor Board allows teams who determine treatment plans for cancer patients - to have a more comprehensive view of each patient in one place.

Here is a bit more of how the solution works. The integration of GE Healthcare’s medical image viewer into Navify Tumor Board 2.0 enables radiologists to upload their patient records to the same dashboard where patient files from other disciplines in the cancer care team are stored.

Having complete patient diagnostic information in one location helps specialists use the limited time they have during tumor boards to review all relevant files quickly and align on the best possible treatment plan for each cancer patient.

“We are delighted to announce the first major milestone of our ongoing collaboration with Roche, as we work together to enable precision healthcare. Workflows around tumor boards can be inefficient, and we hope this single, holistic dashboard - including patient data and images - will enable oncology teams to align more quickly on the most optimal diagnosis and treatment plan for the benefit of each patient,” said Tom McGuinness, President and CEO, GE Healthcare Imaging.

The solution will initially be available in the U.S. and Canada with additional markets to follow. Roche and GE Healthcare began their collaboration in January of 2018.

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like